3-cyclobutene-1,2-dione has been researched along with selfotel in 1 studies
| Studies (3-cyclobutene-1,2-dione) | Trials (3-cyclobutene-1,2-dione) | Recent Studies (post-2010) (3-cyclobutene-1,2-dione) | Studies (selfotel) | Trials (selfotel) | Recent Studies (post-2010) (selfotel) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 250 | 9 | 10 |
| Protein | Taxonomy | 3-cyclobutene-1,2-dione (IC50) | selfotel (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.3428 | |
| Glutamate receptor 1 | Homo sapiens (human) | 0.967 | |
| Glutamate receptor 2 | Homo sapiens (human) | 0.967 | |
| Glutamate receptor 3 | Homo sapiens (human) | 0.967 | |
| Glutamate receptor 4 | Homo sapiens (human) | 0.967 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.362 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.3428 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.3428 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.3428 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.3428 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.3428 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Gharbia, M; Bramlett, DR; Garrison, DT; Kinney, WA; Kowal, DM; Miller, TL; Moyer, JA; Schmid, J; Tasse, RP; Zaleska, MM | 1 |
1 other study(ies) available for 3-cyclobutene-1,2-dione and selfotel
| Article | Year |
|---|---|
Design and synthesis of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid (EAA-090), a potent N-methyl-D-aspartate antagonist, via the use of 3-cyclobutene-1,2-dione as an achiral alpha-amino acid bioisostere.
Topics: Animals; Azabicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclobutanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Ischemic Attack, Transient; Mice; Models, Chemical; N-Methylaspartate; Organophosphonates; Pipecolic Acids; Piperazines; Rats | 1998 |